GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait?

Year to date, the stock rose 28.2% compared with the industry's 3.7% gain. The stock has also outperformed the sector and the S&P 500 index in this time frame. Image Source: Zacks Investment Research Gilead Outperforms Industry, Sector & S&P 500 Index Key Takeaways Shares of Gilead Sciences, Inc. ((GILD) gained 7.3% after the company reported solid results for the second quarter of 2025 and raised its annual guidance for 2025. Adjusted earnings per share (EPS) of $2.01 beat the Zacks Consensus Estimate of $ ...